Bullous pemphigoid and the pembrolizumab conundrum
Pembrolizumab is an immune checkpoint inhibitor that is gaining widespread use as an immunotherapy for various cancers. With its growing application, a range of immune-related adverse events are being more frequently recognized. Pruritus, lichenoid reaction and eczema are known dermatological advers...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| coleção: | Journal of the Egyptian Women’s Dermatologic Society |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/jewd.jewd_38_25 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|